Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
Using a longitudinal observational cohort of ankylosing spondylitis (AS) patients, we sought to identify progression rates, and factors predictive of spinal progression. As a secondary aim we analyzed the effect of tumor necrosis factor inhibitor (TNFi) treatment on radiographic progression. AS patients who had baseline and follow-up cervical and lumbar X-rays were included in the study. Radiographic damage was assessed by the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). A change of 2 mSASSS units in 2 years was defined as progression. The characteristics of the study group such as demographic, clinical, laboratory, and treatment history were collected. There were 350 patients in the study. The mean mSASSS increased from 9.3 (15.8) units at baseline to 17.7 (21.7) units by the 6th year. Change in mSASSS scores between the 0 to 2, 2 to 4 and 4 to 6 years were 1.23 (2.68), 1.47 (2.86), and 1.52 (3.7) units respectively. Overall 24.3% of the group progressed in 2 years' time. Male sex (HR 2.46, 95%CI 1.05, 5.76), presence of baseline damage (HR 7.98, 95%CI 3.98, 16), increased inflammatory markers (logCRP; HR 1.35, 95%CI 1.07, 1.70) and TNFi use (HR 0.82, 95%CI 0.70, 0.96) were predictive of radiographic progression. There was a 20% reduction in the rate of progression with TNFi. Male sex, presence of baseline damage, active disease state and higher inflammatory markers confer a high-risk group for disease progression. Treatment with TNFi showed a disease modifying effect by slowing the rate of radiographic progression.